False smut of rice is an emerging disease and caused severe damage to hybrids and inbred rice cultivars grown in Asian countries. The objective of the study was to quantify of false smut resistance and identification of donors in some of the advanced breeding lines and rice varieties developed at Punjab Agricultural University, Ludhiana, India. A total of 31 genotypes were evaluated for three years in two planting date per year under field conditions. The lines were categorized into short, medium and long durations based on days to flowering. False smut was quantified using different disease variables such as per cent infected panicle, number of false smut ball per plant and disease score. Disease variables were significantly and positively correlated to each other. The infected panicle ranged 0.0–75.4% was observed among the genotypes. Three advanced lines namely RGS-2 (short), RGM-3 (medium) and RGL-3 (long) showed the lowest ranged 0.0–4.9% of infected panicle as compared to susceptible checks (47.7–75.4%). The genotypes were divided into five groups according to a component of resistance. The third group had the lowest average values (3.3%) of infected panicle as compared to the fifth group with the highest values (36.2%) of the infected panicle. The overall trend of disease variables was higher in short duration genotypes as compared to medium and long durations. Weather factors such as rain fall, rainy days and high relative humidity during the flowering period were favourable for disease development. The genotypes with lower disease variables could be utilized in diseases resistance breeding programme.

“Ethical dilemmas…are rarely simple and stark but are, instead, multifaceted, complex, and gut wrenching for parents and care givers alike.” This is never more the case than when one must treat vulnerable babies who are not, nor ever can be competent to offer us some guidance about that treatment. The ethical problems are heightened when the parents, or the single mother, are incompetent to make decisions themselves, for example, because of drug addiction. In such cases, when the baby is premature and suffering the effects of the drugs the mother has taken, and the mother herself is either no longer available for consultation or so damaged by her own addiction that she is not a reliable decisionmaker, the usual trend In the United States is to initiate treatment and continue until it is virtually certain that the infant will die.

Nationwide, almost 11% of women abuse drugs during their pregnancy. In some communities, these numbers are as high as 25–30%. Drug abuse is not limited to the poor or to African Americans, but is seen among affluent and white Americans as well. It is widespread, irrespective of race or social class. Annually, nearly 375,000 infants are exposed to drugs in America. Because of the terrible suffering caused by these births, and the conflicts caregivers experience in the treatment of these infants, Trollope's quote is very apropos. Although caregivers have good motives in trying to rescue these babies and helping place them in a nurturing environment, despair about this objective is always close to the surface.

We appreciated the important commentary provided by Michelle Oberman on our paper, “Discontinuing Life Support in an Infant of a Drug-Addicted Mother: Whose Decision Is It?” (CQ Vol. 6, No. 1). For the most part we agree with Oberman's analysis of the issues, but there are seven points of variance, either of conception, emphasis, or accuracy. We wish to clarify these and welcome the chance her commentary provided to offer aspects of the social situation surrounding the case we presented.